Among the newer biomarkers for AKI, neutrophil gelatinase-associated lipocalin (NGAL) has failed to differentiate between patients with or without AKI in the presence of sepsis [8,9], while the kidney injury molecule-1 (KIM-1) has not been thoroughly studied in the context of SA-AKI [10]. The gene discussed is LCN2; the disease is Sepsis.